Next Article in Journal
Palliative Sedation—Still a Complex Clinical Issue!
Previous Article in Journal
Practice and Documentation of Palliative Sedation: A Quality Improvement Initiative
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Current Oncology
Volume 21
Issue 2
10.3747/co.21.2027
curroncol-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
Current Oncology is published by MDPI from Volume 28 Issue 1 (2021). Previous articles were published by another publisher in Open Access under a CC-BY (or CC-BY-NC-ND) licence, and they are hosted by MDPI on mdpi.com as a courtesy and upon agreement with Multimed Inc..
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Correction

Corrigendum: A Canadian Perspective on the Safe Administration of Bendamustine and the Prevention and Management of Adverse Events

by
J. Koolwine
1,*,
T. Crosbie
1,
G. Gazzé
2,
R. Turner
3,
J. Wiernikowski
4,5 and
W. Assaily
6
1
Ottawa Hosp, Ottawa, ON K1H 8L6, Canada
2
McGill Univ, Ctr Hlth, Montreal, PQ, Canada
3
Princess Margaret Hosp, Toronto, ON M4X 1K9, Canada
4
Juravinski Hosp, Hamilton, ON, Canada
5
Ctr Canc, Hamilton, ON, Canada
6
New Evidence, Toronto, ON, Canada
*
Author to whom correspondence should be addressed.
Curr. Oncol. 2014, 21(2), 104-105; https://doi.org/10.3747/co.21.2027
Submission received: 2 January 2014 / Revised: 3 February 2014 / Accepted: 4 March 2014 / Published: 1 April 2014

Excerpt

Note: In lieu of an abstract, this is an excerpt from the first page.

In the top right-hand corner of Figure 1 [...]

Share and Cite

MDPI and ACS Style

Koolwine, J.; Crosbie, T.; Gazzé, G.; Turner, R.; Wiernikowski, J.; Assaily, W. Corrigendum: A Canadian Perspective on the Safe Administration of Bendamustine and the Prevention and Management of Adverse Events. Curr. Oncol. 2014, 21, 104-105. https://doi.org/10.3747/co.21.2027

AMA Style

Koolwine J, Crosbie T, Gazzé G, Turner R, Wiernikowski J, Assaily W. Corrigendum: A Canadian Perspective on the Safe Administration of Bendamustine and the Prevention and Management of Adverse Events. Current Oncology. 2014; 21(2):104-105. https://doi.org/10.3747/co.21.2027

Chicago/Turabian Style

Koolwine, J., T. Crosbie, G. Gazzé, R. Turner, J. Wiernikowski, and W. Assaily. 2014. "Corrigendum: A Canadian Perspective on the Safe Administration of Bendamustine and the Prevention and Management of Adverse Events" Current Oncology 21, no. 2: 104-105. https://doi.org/10.3747/co.21.2027

APA Style

Koolwine, J., Crosbie, T., Gazzé, G., Turner, R., Wiernikowski, J., & Assaily, W. (2014). Corrigendum: A Canadian Perspective on the Safe Administration of Bendamustine and the Prevention and Management of Adverse Events. Current Oncology, 21(2), 104-105. https://doi.org/10.3747/co.21.2027

Article Metrics

Back to TopTop